Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NUTIDON-Z is a branded generic nutritional supplement developed and marketed by Ken Pharmaceuticals. It is a combination product containing carbonyl iron, folic acid, vitamin B12 (cyanocobalamin), and zinc sulfate. The formulation is primarily indicated for the treatment and prevention of iron deficiency anemia and other nutritional deficiencies, particularly during periods of increased demand such as pregnancy and lactation. Carbonyl iron provides a high concentration of elemental iron with a favorable safety profile compared to traditional iron salts. Folic acid and vitamin B12 are essential for DNA synthesis and the maturation of red blood cells, while zinc serves as a critical trace mineral for immune function and enzymatic processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on NUTIDON-Z.